<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03807622</url>
  </required_header>
  <id_info>
    <org_study_id>2018-05</org_study_id>
    <nct_id>NCT03807622</nct_id>
  </id_info>
  <brief_title>ClearSight System CHN Study</brief_title>
  <official_title>A Prospective, Nonrandomized, Non-interventional Trial to Evaluate ClearSight System Cardiac Output in China</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Edwards Lifesciences</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Edwards Lifesciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this clinical trial is to demonstrate that cardiac output (CO) as determined
      with the Clinical Platform (Model:EV1000A, Software Version:1.9) in a noninvasive manner is
      comparable to CO as determined by Pulmonary Artery Catheter (PAC) thermodilution (TD). The
      results of this study may be used for registration and regulatory submissions.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 25, 2018</start_date>
  <completion_date type="Actual">October 17, 2019</completion_date>
  <primary_completion_date type="Actual">October 17, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiac Output using the Non-invasive ClearSight System</measure>
    <time_frame>Expected to last no more than 6 hours</time_frame>
    <description>Cardiac Output using the Non-invasive ClearSight System</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The percentage error (PE) between the ClearSight System CO and TD</measure>
    <time_frame>Expected to last no more than 6 hours</time_frame>
    <description>The percentage error (PE) between the ClearSight System CO and TD</description>
  </secondary_outcome>
  <enrollment type="Actual">125</enrollment>
  <condition>Patient With Clinically Indicated Invasive Monitoring</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EV1000NI Clinical Platform: Noninvasive Hemodynamic Monitoring utilizing ClearSight System</intervention_name>
    <description>EV1000NI Clinical Platform: Noninvasive Hemodynamic Monitoring utilizing ClearSight System</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing elective major cardiothoracic surgery with an indwelling PA catheter.
        The surgical intervention includes, but is not limited to, mitral valve surgery or coronary
        artery bypass grafting.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects must be at least 18 years of age

          -  Subjects provide written informed consent prior to trial procedures

          -  Subjects' height and weight must be accurately obtained prior to study start.

        Exclusion Criteria:

          -  Aortic or tricuspid valve regurgitation

          -  Aortic stenosis or aneurysms

          -  Cardiac rhythm disorder

          -  Patients with extreme contraction of the smooth muscle in the arteries and arterioles
             in the lower arm and hand, such as may be present in patients with Raynaud's or
             Buerger's disease or with extremely cold hands

          -  Inability to place the finger cuff appropriately due to subject anatomy or condition

          -  Known pregnancy

          -  Patients being treated with an intra-aortic balloon pump

          -  Patient is currently participating in an investigational drug or another device study
             that clinically interferes with the study endpoints

          -  Intracardiac shunt
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Fuwai Cardiovascular Disease Hospital, Chinese Academy of Medical Sciences, Beijing</name>
      <address>
        <city>Xicheng</city>
        <state>Beijing</state>
        <zip>100037</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wuhan Asia Heart Hospital</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei Sheng</state>
        <zip>430072</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tianjin Chest Hospital</name>
      <address>
        <city>Heping</city>
        <state>Tianjin</state>
        <zip>300300</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>January 15, 2019</study_first_submitted>
  <study_first_submitted_qc>January 15, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 17, 2019</study_first_posted>
  <last_update_submitted>November 8, 2019</last_update_submitted>
  <last_update_submitted_qc>November 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Elective Major Cardiothoracic</keyword>
  <keyword>Mitral Valve Surgery</keyword>
  <keyword>Coronary Artery Bypass Grafting</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

